Profil
- Teaching students of medicine, dental medicine, pharmacy, biomedicine, and biology as well as graduate students at the Graduate School for Cellular and Biomedical Sciences (GCB)
- Five research groups
- Investigation of pathophysiological processes that contribute to inflammation and tumor diseases
- Aim: Discovering new drug targets; developing and validating new drugs in preclinical models
Externe Partner
Institutes of Biochemistry, Experimental Immunology and Molecular Cancer Research, University of Zürich, Zürich, Switzerland; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany; Pharmazentrum Frankfurt/ZAFES, University Hospital and Goethe University, Frankfurt/Main, Germany; Department of Medicine, University of Toronto, Toronto, Canada; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Swiss EoE Research Group, Olten, Switzerland, University Kazan, Russia, Centre de Recherche CIMI, Sorbonne Université, Paris, France
Grants
- Swiss National Science Foundation (grant No. 320030_219451 / 1; 310030_219605; 310030_184816; 310030_184757/1; 310030-201199; 310030-212418; 310030E_205559 / 1 (co-applicant)
- Swiss Cancer League KFS-4958-02-2020; KFS-515-08-2020
- Bürgi-Fonds
- Novartis Foundation for Biological-Medical Research
- Bern Center for Precision Medicine (BCPM) Grant
- Innosuisse-Swiss Innovation Agency #40922.1 IP-LS; #52202.1 IP-LS (co-applicant)
- Russian Government Program (075-15.2021-600)
- China Scholarship Council
